Search

Search Results

• 

  GISEA: an Italian biological agents registry in rheumatology

  G. Lapadula, G. Ferraccioli, C. Ferri, L. Punzi, F. Trotta

  155-164

  09-11-2011

  https://doi.org/10.4081/reumatismo.2011.155

  2635

  PDF: 1684

• CO:09:1 | The impact of sex and gender on fibromyalgia syndrome: data from the Italian Fibromyalgia Registry Martina Favretti¹, Cristina Iannuccelli², Giulio Dolcini¹, Sonia Farah³, Marco Di Carlo³, Giuseppina Tramontano⁴, Giorgia Ferrari⁴, Fabiola Atzeni⁵, Greta Pellegrino^6|7, Piercarlo Sarzi-Puttini^6|7, Fausto Salaffi³, Manuela Di Franco⁸. | ¹Dipartimento di Medicina Molecolare, Sapienza Università di Roma; ²UOC Reumatologia, Policlinico Umberto I, Roma; ³Unità di Reumatologia, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Jesi (AN); ⁴Unità di Reumatologia, Dipartimento di Specialità Mediche, Regional Health Trust 3, Genova; ⁵Unità di Reumatologia, Dipartimento di Medicina Interna, Università di Messina; ⁶Unità di Reumatologia, IRCCS Ospedale Galeazzi - Sant'Ambrogio, Milano; ⁷Dipartimento di Scienze Biomediche e Cliniche, Università degli studi di Milano; ⁸UOC Reumatologia, Dipartimento di Scienze Cliniche Internistiche Anestesiologiche e Cardiovascolari, La Sapienza, Roma, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1986

  160

• PO:07:099 | Survival on therapy of certolizumab pegol in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: 8-year data from an Italian multicenter register Maria Manara¹, Gilberto Cincinelli^1|2, Marco Fornaro³, Simone Perniola⁴, Elisa Gremese⁵, Chiara Bazzani⁶, Serena Bugatti⁷, Francesca Romana Spinelli⁸, Rosario Foti⁹, Marco Sebastiani¹⁰, Alberto Cauli¹¹, Fabiola Atzeni¹², Giovanni Lapadula¹³, Gianfranco Ferraccioli¹⁴, Fabrizio Conti⁸, Florenzo Iannone³, Roberto Caporali^1|2 | ¹Department of Rheumatology and Medical Sciences, ASST G. Pini-CTO Milano; ²Department of Clinical Sciences and Community Health, University of Milan; ³Department of Precision and Regenerative Medicine and Ionian Area, University of Bari; ⁴Clinical Immunology Division, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma; ⁵Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano (MI); ⁶Unit of Rheumatology and Clinical Immunology, ASST Spedali Civili Brescia; ⁷Department of Internal Medicine and Therapeutics, Università di Pavia; ⁸Rheumatology Unit, Dipartimento Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza University, Roma; ⁹Rheumatology Unit, San Marco Hospital, Policlinico University of Catania; ¹⁰Rheumatology Unit, AUSL Piacenza, University of Parma; ¹¹UOC di Reumatologia, Dipartimento di Scienze Mediche e Sanità Pubblica, Azienda Ospedaliero-Universitaria di Cagliari; ¹²Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina; ¹³Gruppo Italiano di Studio sulla Early Arthritis, GISEA, Bari; ¹⁴Department of Medicine, Università Cattolica del Sacro Cuore, Fondazione IRCCS Policlinico Gemelli, Roma, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2137

  156

• CO:09:6 | Risk of disease flare during pregnancy and postpartum in inflammatory arthritis: association with therapy discontinuation in the prospective P-RHEUM.it study Dina Zucchi¹, Chiara Tani¹, Francesca Crisafulli², Alessia Gatti², Maria Gerosa³, Cecilia Chighizola³, Melissa Padovan⁴, Salvatore D'Angelo⁵, Florenzo Iannone⁶, Maria Sole Chimenti⁷, Claudia Lomater⁸, Francesca Serale⁹, Veronique Ramoni¹⁰, Oscar Epis¹¹, Bernd Raffeiner¹², Ariela Hoxha¹³, Andrea Doria¹⁴, Leonardo Santo¹⁵, Valentina Canti¹⁶, Francesca Bellisai¹⁷, Giovanna Cuomo¹⁸, on behalf of the P-Rheumit Investigators¹⁹, Greta Carrara²⁰, Cristina Di Nicola²⁰, Davide Rozza²⁰, Carlo Alberto Scirè²⁰, Maria Chiara Gerardi¹¹, Angela Tincani², Laura Andreoli², Marta Mosca¹. | ¹Rheumatology Unit, University of Pisa and Azienda Ospedaliero Universitaria Pisana; ²Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia; ³Clinical Rheumatology Division, ASST Gaetano Pini-CTO and University of Milano; ⁴Rheumatology Unit, Azienda Ospedaliero-Universitaria S. Anna and University of Ferrara; ⁵Rheumatology Department of Lucania - San Carlo Hospital, Potenza; ⁶Rheumatology Unit, DiMePRE-J, University of Bari; ⁷Department of Systems Medicine, Rheumatology, Allergology and Clinical Immunology, University of Rome-Tor Vergata, Roma; ⁸Torino Academic Rheumatology Center, A.O. Mauriziano di Torino, University of Torino; ⁹Rheumatology Unit, ASL CN1 Cuneo; ¹⁰Internal Medicine Department, ASST Lodi - Ospedale Maggiore di Lodi; ¹¹Division of Rheumatology, Multispecialist Medical Department, Grande Ospedale Metropolitano Niguarda, Milano; ¹²Department of Rheumatology, Central Hospital of Bolzano SABES-ASDAA, Bolzano; ¹³General Medicine and Thrombosis and Hemorrhagic Unit, Department of Medicine, University of Padova; ¹⁴Rheumatology Unit, Department of Medicine, University of Padova; ¹⁵Rheumatology Unit, Mons. Dimiccoli Hospital, Barletta; ¹⁶Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milano; ¹⁷Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena; ¹⁸Precision Medicine Department, University of Campania L. Vanvitelli, Napoli; ¹⁹The Italian Society for Rheumatology; ²⁰Epidemiology Research Unit of the Italian Society for Rheumatology, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1989

  148

• PO:33:199 | Prevalence and clinical associations of antiphospholipid antibodies in patients with systemic sclerosis in the SPRING-SIR registry Antonio Tonutti^1|2, Ilaria Cavazzana³, Angela Ceribelli^1|2, Maria De Santis^1|2, Giacomo De Luca^4|5, Maria Grazia Lazzaroni³, Franco Franceschini³, Carlo Selmi^1|2, Valeria Riccieri⁶, Silvia Laura Bosello⁷, Fabio Cacciapaglia⁸, Veronica Codullo⁹, Francesca Ingegnoli¹⁰, Dilia Giuggioli¹¹, Rossella De Angelis¹², Clodoveo Ferri¹¹, Marco Matucci-Cerinic^4|5 | ¹Department of Biomedical Sciences, Humanitas Universityce Pieve Emanuele, Milan, Italy; ²Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; ³Rheumatology and Clinical Immunology - ASST Spedali Civili Brescia - Department of Clinical and Experimental Sciences - Brescia, Italy; ⁴Vita-Salute San Raffaele University Milan, Italy; ⁵Unit of Immunology, Rheumatology, Allergy and Rare Diseases UnIRAR and INFLAGE Initiative, IRCCS San Raffaele Hospital Milan, Italy; ⁶University of Rome La Sapienza Rome, Italy; ⁷Catholic University of Sacred Heart Rome, Italy; ⁸LUM University Bari, Italy; ⁹Rheumatology Unit, Fondazione IRCCS Policlinico San Matteo Pavia, Italy; ¹⁰University of Milan Milan, Italy; ¹¹University of Modena and Reggio Emilia Modena, Italy; ¹²Politechnic University of Marche Ancona, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2376

  15

• PO:19:279 | Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry Jessica Sbalchiero¹, Antonio Vitale¹, Valeria Caggiano¹, Abdurrahman Tufan², Ezgi Batu³, Gaafar Ragab⁴, Seza Ozen³, Jurgen Sota¹, Carla Gaggiano¹, Ali Sahin⁵, Petros Sfikakis⁶, Francesca Li Gobbi⁷, Giacomo Emmi⁸, Jose Rodriguez⁹, Piero Ruscitti¹⁰, Paolo Sfriso¹¹, Ewa Szewczyk¹², Giuseppe Lopalco¹³, Alberto Balistreri¹⁴, Claudia Fabiani¹⁵, Bruno Frediani¹, Luca Cantarini¹ | ¹Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy; ²Department of Internal Medicine, Division of Rheumatology, Gazi University Hospital Ankara, Turkey; ³Division of Pediatric Rheumatology, Department of Pediatrics, Hacettepe University School of Medicine Ankara, Turkey; ⁴Internal Medicine Department, Rheumatology and Clinical Immunology Unit, Faculty of Medicine, Cairo University Giza, Egypt; ⁵Division of Rheumatology, Department of Internal Medicine, Sivas Cumhuriyet University Medical Faculty Sivas, Turkey; ⁶Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens Athens, Greece; ⁷Rheumatology Unit, Hospital S. Giovanni di Dio, Azienda USL-Toscana Centro Florence, Italy; ⁸Clinical Medicine and Rheumatology Unit, Cattinara University Hospital Trieste, Italy; ⁹Department of Autoimmune Diseases, Institut Investigacions Biomediques August Pi I Sunyer, University of Barcelona Barcelona Spain; ¹⁰Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy; ¹¹Rheumatology Unit, Department of Medicine, University of Padua Padua, Italy; ¹²7Department of Internal Medicine, Pneumonology, Allergology, Clinical Immunology and Rare Diseases, Military Institute o Warsaw, Poland; ¹³Department of Precision and Regenerative Medicine and Ionian Area DiMePRe-J Policlinic Hospital, University of Bari Bari, Italy; ¹⁴Bioengineering and Biomedical Data Science Lab, Department of Medical Biotechnologies, University of Siena Siena, Italy; ¹⁵Ophthalmology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena Siena, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2339

  36

• CO:02:2 | Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis: real world data from an Italian National Registry Valerio Fiorilli¹, Francesca Romana Spinelli¹, Florenzo Iannone², Chiara Bazzani³, Alberto Cauli⁴, Rosario Foti⁵, Marcello Govoni⁶, Francesco Paolo Cantatore⁷, Fabiola Atzeni⁸, Roberto Caporali⁹, Marco Sebastiani¹⁰, Roberta Ramonda¹¹, Serena Bugatti¹², Elisa Gremese¹³, Maria Sole Chimenti¹⁴, Bruno Frediani¹⁵, Maurizio Rossini¹⁶, Angelo Semeraro¹⁷, Leonardo Santo¹⁸, Gianfranco Ferraccioli¹⁹, Giovanni Lapadula²⁰, Fabrizio Conti¹. | ¹Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma; ²Dipartimento di Medicina di Precisione e Rigenerativa e Area Jonica, Università degli Studi Aldo Moro, Bari; ³ASST Spedali Civili di Brescia, Unità di Reumatologia ed Immunologia Clinica, Brescia; ⁴Dipartimento di Scienze Mediche e Sanità Pubblica, Università degli Studi di Cagliari; ⁵A.O.U. Policlinico S. Marco, UOS Reumatologia, Catania; ⁶Dipartimento di Scienze Mediche, Università di Ferrara; ⁷Unità di Reumatologia,  Dipartimento di Medicina Specialistica, Università di Foggia; ⁸Dipartimento di Medicina Interna e Terapia Medica, UOC di Reumatologia, Università di Messina; ⁹Dipartimento di Scienze Cliniche e di Comunità, Università di Milano; ¹⁰Dipartimento di Medicina e Chirurgia, Università di Parma; ¹¹Unità di Reumatologia, Dipartimento di Medicina, Università di Padova; ¹²Dipartimento di Medicina Interna e Terapia Medica, Università di Pavia, ; ¹³IRCCS Istituto Clinico Humanitas, Dipartimento di Scienze Biomediche, Milano; ¹⁴Dipartimento di Medicina dei Sistemi, Università degli Studi di Roma-Tor Vergata, ; ¹⁵Dipartimento di Medicina Clinica e Scienze Immunologiche, Università di Siena; ¹⁶Dipartimento di Medicina, Università di Verona; ¹⁷Presidio Ospedaliero Valle d'Itria, Unità Operativa di Reumatologia, Martina Franca; ¹⁸Presidio Ospedaliero "Mons. Dimiccoli", Unità Operativa Semplice di Reumatologia, Barletta; ¹⁹Gruppo Italiano di Studio sulla Early Arthritis, GISEA, Roma; ²⁰Gruppo Italiano di Studio sulla early Arthritis, GISEA, Bari, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1966

  178

• PO:31:175 | Characterizing gastrointestinal involvement in systemic sclerosis: insights from the national systemic sclerosis progression investigation registry of the Italian Society of Rheumatology Francesco Bonomi¹, Cosimo Bruni^1|2, Silvia Laura Bosello³, Fabio Cacciapaglia^4|5, Corrado Campochiaro⁶, Roberto Caporali⁷, Veronica Codullo⁸, Maria Antonietta D'Agostino³, Lorenzo Dagna⁶, Rossella De Angelis⁹, Giacomo De Luca⁶, Dilia Giuggioli¹⁰, Serena Guiducci¹, Florenzo Iannone⁴, Francesca Ingegnoli⁷, Carlomaurizio Montecucco⁸, Valeria Riccieri¹¹, Clodoveo Ferri¹⁰, Marco Matucci Cerinic⁶, Silvia Bellando Randone¹. | ¹Scleroderma Unit, Division of Rheumatology AOUC, and Department of Experimental and Clinical Medicine, Uni. of Florence, Firenze, Italy; ²Department of Rheumatology, University Hospital Zurich, University of Zurich Zurigo Switzerland; ³UOC of Rheumatology and Clinical Immunology, Catholic University of the Sacred Heart, Fondazione Policlinico A. Gemelli, Roma, Italy; ⁴Rheumatology Unit, Department of Emergency Surgery and Organ Transplantations, University of Bari, Bari, Italy; ⁵Rheumatology Service, F. Miulli General Hospital - Department of Medicine and Surgery, LUM 'G. De Gennaro', Casamassima, Italy; ⁶Unit of Immunology, Rheumatology, Allergy and Rare Diseases and Inflammation, fibrosis and ageing initiative, UniSR, Milano, Italy; ⁷Division of Clinical Rheumatology, ASST Pini and Università degli studi di Milano, Milano, Italy; ⁸Department of Rheumatology, Policlinico San Matteo, Pavia, Italy; ⁹Rheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy; ¹⁰Rheumatology Unit, School of Medicine, University of Modena and Reggio Emilia, Modena, Italy; ¹¹Department of Rheumatology, Sapienza University of Rome, Roma, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2076

  151

• PO:01:003 | Sex-based differences in 2 years treatment outcomes with b/ts-DMARDs in psoriatic arthritis: from real-world evidence to predictive modeling from the Gruppo Italiano Studio Early Arthritis (GISEA) prospective registry Simone Perniola¹, Florenzo Iannone¹, Francesco Paolo Cantatore², Angelo Semeraro³, Leonardo Santo⁴, Roberto Gorla⁵, Alberto Cauli⁶, Roberto Felice Caporali⁷, Bruno Frediani⁸, Rosario Foti⁹, Fabrizio Conti¹⁰, Marco Sebastiani¹¹, Maria Sole Chimenti¹², Roberta Ramonda¹³, Fabiola Atzeni¹⁴, Maurizio Rossini¹⁵, Serena Bugatti¹⁶, Serena Guiducci¹⁷, Giovanni Lapadula¹, Gianfranco Ferraccioli¹⁸, Francesca Romana Spinelli¹⁰, Elisa Gremese¹⁹. | ¹Rheumatology Unit, DiMePReJ, University of Bari, Bari; ²Rheumatology Unit, Department of Medical and Surgical Sciences, Azienda Ospedaliero-Universitaria Policlinico Riuniti, Foggia; ³Rheumatology Unit, Martina Franca Hospital; ⁴Rheumatology Unit, ASL BT, P.O. Barletta; ⁵Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia; ⁶Rheumatology Unit, Department of Medical Science and Public Health, University of Cagliari, Monserrato (CA); ⁷Rheumatology Unit, Dipartimento di Reumatologia e Scienze Mediche, ASST PINI-CTO, University of Milano, Milano; ⁸Rheumatology Unit, Azienda Ospedaliero Universitaria Senese, Siena; ⁹Rheumatology Unit, A.O.U. Policlinico S. Marco, Catania; ¹⁰Rheumatology Unit, Department of Clinical Internal, Anesthesiologic and CV Sciences, Sapienza University of Rome, Roma; ¹¹Rheumatology Unit, AUSL Piacenza, University of Parma, Parma; ¹²Rheumatology, Department of Systems Medicine, University of Rome Tor Vergata, Roma; ¹³Rheumatology Unit, DIMED, University of Padua, Padova; ¹⁴Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, Messina; ¹⁵Rheumatology Unit, Department of Medicine, University of Verona, Verona; ¹⁶Division of Rheumatology, Dept. of Internal Medicine and Therapy, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia; ¹⁷Division of Rheumatology, Department of Experimental and Clinical Medicine, University of Firenze, Firenze; ¹⁸Department of Medicine, Catholic University of the Sacred Heart, Fondazione Policlinico Gemelli IRCCS, Roma; ¹⁹Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Humanitas University, Rozzano (MI), Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2000

  192

• PO:08:119 | Infusional Advantage: Rituximab’s Role in Enhancing Adherence in Multimorbid Rheumatoid Arthritis Marco Capodiferro¹, Daniele Domanico¹, Angelica Napoletano¹, Giulia Righetti², Patrizia Suppressa², Vincenzo Venerito¹, Giuseppe Lopalco¹, Florenzo Iannone¹, Fabio Cacciapaglia^1|2 | ¹Rheumatology Unit, Department of Precision and Regenerative Medicine and Jonian Area DiMePRe-J University of Bari, Italy; ²Department of Medicine and Surgery, Miulli General Hospital Acquaviva delle Fonti - LUM University Casamassima Bari Acquaviva delle Fonti, Bari, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2307

  14
• 

  Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies

  Stefano Stano, Fabio Cacciapaglia, Laura Coladonato, Giuseppe Lopalco, Florenzo Iannone, Marco Fornaro

  07-04-2025

  https://doi.org/10.4081/reumatismo.2025.1817

  2189

  PDF: 415

  SUPPLEMENTARY MATERIAL: 342
• 

  Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)

  G. Carlino, M. Fornaro, L. Santo, R. Bucci, A. Semeraro, L. Quarta, F. D'Onofrio, A. Marsico, C. Zuccaro, P.C. Falappone, D. Mazzotta, F.P. Cantatore, M. Muratore, F. Iannone

  24-30

  01-04-2019

  https://doi.org/10.4081/reumatismo.2019.1154

  1857

  PDF: 1264
• 

  Long-term efficacy of intra-articular viscosupplementation in delaying hip osteoarthritis radiographic progression: a retrospective, non-controlled study from the ANTIAGE registry

  Alberto Migliore, Nazzareno Iannarelli, Antonio Devito, Raffaele Saporito, Luca Saccone, Irene Beriotto, Michele Grassi, Eugenio Cunego, Annamaria Paglionico, Sandro Tormenta

  25-02-2026

  https://doi.org/10.4081/reumatismo.2026.1917

  837

  PDF: 94

• PO:31:161 | First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: clinical associations from the SPRING-SIR registry Antonio Tonutti^1|2, Francesca Motta^1|2, Rossella De Angelis³, Valeria Riccieri⁴, Silvia Laura Bosello⁵, Fabio Cacciapaglia⁶, Veronica Codullo⁷, Giacomo De Luca⁸, Francesca Ingegnoli⁹, Dilia Giuggioli¹⁰, Clodoveo Ferri¹⁰, Marco Matucci-Cerinic⁸, Carlo Selmi^1|2, Maria De Santis^1|2 | ¹Department of Biomedical Sciences, Humanitas University Pieve Emanuele, Milan, Italy; ²Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; ³Università Politecnica delle Marche Ancona, Italy; ⁴Università degli Studi di Roma La Sapienza Roma, Italy; ⁵Università Cattolica del Sacro Cuore Roma, Italy; ⁶Università degli Studi di Bari Aldo Moro Bari, Italy; ⁷Reumatologia, Fondazione IRCCS Policlinico San Matteo Pavia, Italy; ⁸Università Vita-Salute San Raffaele Milano, Italy; ⁹Università degli Studi di Milano, Italy; ¹⁰Università degli Studi di Modena e Reggio Emilia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2366

  32